Form 4: Oracle CEO Magouyrk Granted 2.59M Stock Options

Oracle CEO Clayton M. Magouyrk was granted 2,593,530 stock options with an exercise price of $308.46, vesting annually over four years.

Summary

• Oracle's Chief Executive Officer, Clayton M. Magouyrk, was granted 2,593,530 stock options.
• The stock options have an exercise price of $308.46 per share.
• The transaction date for this grant was September 24, 2025.
• The options will vest at a rate of 25% annually on each anniversary of the grant date.
• The expiration date for these stock options is September 24, 2035.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged trading plan.

Sentiment

Score: 7

Explanation: The grant of stock options to the CEO is generally a positive signal, indicating a commitment to long-term executive retention and performance alignment with shareholders. The Rule 10b5-1 plan also adds a layer of transparency.

Positives

• The grant of a significant number of stock options aligns the CEO's long-term financial interests with those of Oracle's shareholders, incentivizing sustained company performance.
• The 10-year expiration period provides a substantial window for the options to become in-the-money, reflecting a long-term commitment.
• The use of a Rule 10b5-1 plan enhances transparency and demonstrates a proactive approach to compliance regarding insider trading.

Negatives

• The exercise price of $308.46 is substantial, meaning the stock price must appreciate significantly from its current level (not specified in filing, but implied by a future grant date) for the options to hold intrinsic value, posing a performance hurdle.
• Future exercise of these options could lead to dilution for existing shareholders, although this is a common aspect of equity compensation.

Future Outlook

The vesting schedule of 25% annually over four years indicates a long-term incentive structure designed to retain the CEO and motivate sustained performance through at least September 2029.

Industry Context

Executive stock option grants are a standard component of compensation packages for senior leadership in the technology industry. This practice aims to align the interests of executives with those of shareholders by tying a significant portion of their potential compensation to the company's stock performance. Oracle, as a major enterprise software and cloud services provider, utilizes such incentives to attract and retain top talent in a competitive market.

Comparison to Industry Standards

• Executive stock option grants are a common component of compensation packages in the technology industry, designed to align management incentives with long-term shareholder value.
• The size and terms of this grant are generally consistent with practices for senior executives at large-cap technology companies, though specific comparisons would require detailed peer group analysis not provided in this filing.

Corporate Governance

Stakeholder Impact

• Shareholders: Potential for long-term value creation through aligned executive incentives; potential future dilution upon exercise of options.
• Executive (Clayton M. Magouyrk): Significant long-term incentive and wealth creation opportunity tied directly to company performance.

Next Steps

• The stock options will vest annually at 25% on each anniversary of the September 24, 2025 grant date.

Key Dates

Keywords

Oracle, ORCL, Stock Option, Executive Compensation, Form 4, Insider Transaction, Equity Grant, CEO Compensation, Rule 10b5-1